Steven F. Strandberg - Net Worth and Insider Trading

Steven F. Strandberg Net Worth

The estimated net worth of Steven F. Strandberg is at least $577,735 dollars as of 2024-04-28. Steven F. Strandberg is the Director of NetSuite Inc and owns about 6,395 shares of NetSuite Inc (N) stock worth over $577,724. Steven F. Strandberg is also the Director of Apotheca Biosciences Inc and owns about 54,215 shares of Apotheca Biosciences Inc (CBDC) stock worth over $11. Details can be seen in Steven F. Strandberg's Latest Holdings Summary section.

Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Steven F. Strandberg has not made any transactions after 2019-08-09 and currently still holds the listed stock(s).

Transaction Summary of Steven F. Strandberg

To

Steven F. Strandberg Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Steven F. Strandberg owns 1 companies in total, including Crescent Capital BDC Inc (CCAP) .

Click here to see the complete history of Steven F. Strandberg’s form 4 insider trades.

Insider Ownership Summary of Steven F. Strandberg

Ticker Comapny Transaction Date Type of Owner
CCAP Crescent Capital BDC Inc 2022-12-31 director

Steven F. Strandberg Latest Holdings Summary

Steven F. Strandberg currently owns a total of 2 stocks. Among these stocks, Steven F. Strandberg owns 6,395 shares of NetSuite Inc (N) as of July 15, 2015, with a value of $577,724 and a weighting of 100%. Steven F. Strandberg also owns 54,215 shares of Apotheca Biosciences Inc (CBDC) as of August 9, 2019, with a value of $11 and a weighting of 0%.

Latest Holdings of Steven F. Strandberg

Ticker Comapny Latest Transaction Date Shares Owned Current Price ($) Current Value ($)
N NetSuite Inc 2015-07-15 6,395 90.34 577,724
CBDC Apotheca Biosciences Inc 2019-08-09 54,215 0.00 11

Holding Weightings of Steven F. Strandberg


Steven F. Strandberg Form 4 Trading Tracker

According to the SEC Form 4 filings, Steven F. Strandberg has made a total of 0 transactions in NetSuite Inc (N) over the past 5 years. The most-recent trade in NetSuite Inc is the acquisition of 6,395 shares on July 15, 2015, which cost Steven F. Strandberg around $127,900.

According to the SEC Form 4 filings, Steven F. Strandberg has made a total of 3 transactions in Apotheca Biosciences Inc (CBDC) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Apotheca Biosciences Inc is the acquisition of 2,982 shares on August 9, 2019, which cost Steven F. Strandberg around $59,014.

Insider Trading History of Steven F. Strandberg

No transactions are available. GuruFocus only tracks and displays the purchase and sale of non-derivative security in open market or private transactions from SEC filings with the transaction code of P or S.
Total 0
  • 1
Only the transactions in Open Market or Private Sale at the market prices are included. Other transactions such as conversion of derivative security or exercise of options are not included. Insiders are limited to only officers and/or directors of the company.

Steven F. Strandberg Trading Performance

GuruFocus tracks the stock performance after each of Steven F. Strandberg's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Steven F. Strandberg is -21.15%. GuruFocus also compares Steven F. Strandberg's trading performance to market benchmark return within the same time period. The performance of stocks bought by Steven F. Strandberg within 3 months outperforms 2 times out of 4 transactions in total compared to the return of S&P 500 within the same period.

You can select different timeframes to see how Steven F. Strandberg's insider trading performs compared to the benchmark.

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Performance of Steven F. Strandberg

Average Return

-29.18%

Average return per transaction

Outperforming Transactions

25%

1 out of 4 outperforming transactions.
Each transaction is measured over a period and compared to .
1 Month 3 Months 6 Months 1 Year 2 Years 3 Years
Return(%) -10.37 -21.15 -53.94 -29.18 -77.88
Relative Return to S&P 500(%) -9.29 -21.99 -57.61 -35.67 -99.73

Steven F. Strandberg Ownership Network

Ownership Network List of Steven F. Strandberg

No Data

Ownership Network Relation of Steven F. Strandberg


Steven F. Strandberg Owned Company Details

What does Crescent Capital BDC Inc do?

Who are the key executives at Crescent Capital BDC Inc?

Steven F. Strandberg is the director of Crescent Capital BDC Inc. Other key executives at Crescent Capital BDC Inc include Secretary George Hawley , Chief Financial Officer Gerhard Lombard , and Senior Vice President Erik G Barrios .

Crescent Capital BDC Inc (CCAP) Insider Trades Summary

In summary, during the past 3 months, insiders sold 0 shares of Crescent Capital BDC Inc (CCAP) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Crescent Capital BDC Inc (CCAP) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.

Crescent Capital BDC Inc (CCAP)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Crescent Capital BDC Inc Insider Transactions

No Available Data

Steven F. Strandberg Mailing Address

Above is the net worth, insider trading, and ownership report for Steven F. Strandberg. You might contact Steven F. Strandberg via mailing address: C/o Crescent Capital Bdc, Inc., 11100 Santa Monica Blvd., Suite 2000, Los Angeles Ca 90025.

Discussions on Steven F. Strandberg

No discussions yet.